SAN DIEGO, CA / ACCESSWIRE / November 26, 2024 / Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) publicly traded securities between February 28, 2020 and September 26, 2024, all dates inclusive (the "Class Period"), have until Monday, December 16, 2024 to seek appointment as lead plaintiff of the Acadia Healthcare class action lawsuit. Captioned Kachrodia v.
NEW ORLEANS, LA / ACCESSWIRE / November 25, 2024 / Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until December 16, 2024 to file lead plaintiff applications in a securities class action lawsuit against Acadia Healthcare Company, Inc. (NASDAQ:ACHC), if they purchased the Company's securities between February 28, 2020 and October 18, 2024, inclusive (the "Class Period").
NEW YORK, NY / ACCESSWIRE / November 25, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that it has filed a lawsuit against Acadia Healthcare Company, Inc. (NASDAQ:ACHC) and certain of the Company's senior executives. If you invested in Acadia Healthcare, you are encouraged to obtain additional information by visiting Click Here Investors have until December 16, 2024 to ask the Court to be appointed to lead the case.
LOS ANGELES, CA / ACCESSWIRE / November 25, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Acadia Healthcare Company, Inc. ("Acadia" or "the Company") (NASDAQ:ACHC) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 28, 2020 and September 26, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before December 16, 2024.
NEW YORK CITY, NY / ACCESSWIRE / November 25, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Acadia Healthcare Company, Inc. ("Acadia Healthcare" or "the Company") (NASDAQ:ACHC) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Acadia Healthcare securities between February 28, 2020, and October 18, 2024, inclusive (the "Class Period").
LOS ANGELES, CA / ACCESSWIRE / November 24, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Acadia Healthcare Company, Inc. ("Acadia" or "the Company") (NASDAQ:ACHC) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 28, 2020 and September 26, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before December 16, 2024.
NEW YORK CITY, NY / ACCESSWIRE / November 24, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Acadia Healthcare Company, Inc. ("Acadia Healthcare" or "the Company") (NASDAQ:ACHC) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Acadia Healthcare securities between February 28, 2020, and October 18, 2024, inclusive (the "Class Period").
LOS ANGELES, CA / ACCESSWIRE / November 23, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Acadia Healthcare Company, Inc. ("Acadia" or "the Company") (NASDAQ:ACHC) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 28, 2020 and September 26, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before December 16, 2024.
NEW YORK, NY / ACCESSWIRE / November 22, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that it has filed a lawsuit against Acadia Healthcare Company, Inc. (NASDAQ:ACHC) and certain of the Company's senior executives. If you invested in Acadia Healthcare, you are encouraged to obtain additional information by visiting Click Here Investors have until December 16, 2024 to ask the Court to be appointed to lead the case.
SAN FRANCISCO, CA / ACCESSWIRE / November 22, 2024 / Acadia Healthcare Company (NASDAQ:ACHC) is facing securities class-action lawsuits by investors alleging the company misled them about its business practices. The more recent lawsuit filed on October 29, 2024 expanded the Class Period to end on Oct. 18, 2024 after The New York Times reported that the Veterans Affairs Department has opened an investigation into Acadia, news which sent the price of Acadia shares sharply lower on Oct. 18, 2024.
LOS ANGELES, CA / ACCESSWIRE / November 22, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Acadia Healthcare Company, Inc. ("Acadia" or "the Company") (NASDAQ:ACHC) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 28, 2020 and September 26, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before December 16, 2024.
NEW YORK, NY / ACCESSWIRE / November 22, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Acadia Healthcare Company, Inc. ("Acadia" or the "Company") (NASDAQ:ACHC). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.